In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 1, 2007, Pages 56-61

  Chang, Ping Chin ^a   Li, Hua Yu ^a   Tang, Hung Jen ^a   Liu, Jien Wei ^b   Wang, Jhi Joung ^a   Chuang, Yin Ching ^a,b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Baicalein; Drug synergism; Enterococcus; Microbial sensitivity tests; Vancomycin resistance

Indexed keywords

AMPICILLIN; BAICALEIN; GENTAMICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; FLAVANONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DILUTION; DRUG POTENTIATION; IN VITRO STUDY; INCUBATION TIME; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIAL INFECTION; DRUG EFFECT; ENTEROCOCCUS; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; ENTEROCOCCUS; ENZYME INHIBITORS; FLAVANONES; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN;

EID: 34347403272     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999; 29:239-44.
2. Wang YS. Pharmacology and applications of Chinese herbs. Beijing: People's Health Publishing House; 1983:1022-7.
3. Koda A, Nagai H, Wada H. Pharmacological actions of baicalin and baicalein. 2. On passive anaphylaxis. Nippon Yakurigaku Zasshi. 1970;66:237-47. [In Japanese].
4. Kubo M, Matsuda H, Tanaka M, Kimura Y, Okuda H, Higashino M, et al. Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. Chem Pharm Bull (Tokyo). 1984;32:2724-9.
5. Wakabayashi I. Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol Toxicol. 1999;84:288-91.
6. Kimuya Y, Kubo M, Tani T, Arichi S, Okuda H. Studies on Scutellariae radix. IV. Effects on lipid peroxidation in rat liver. Chem Pharm Bull (Tokyo). 1981;29:2610-7.
7. Tsao TF, Newman MG, Kwok YY, Horikoshi AK. Effect of Chinese and western antimicrobial agents on selected oral bacteria. J Dent Res. 1982;61:1103-6.
8. Liu IX, Durham DG, Richards RM. Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus. J Pharm Pharmacol. 2000;52:361-6.
9. Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, et al. Baicalin, the predominant flavone glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol. 2000;52:1563-8.
10. Facklam RR, Sahm DF, Teixeira LM. Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RT, eds. Manual of clinical microbiology, 7th ed. Washington, DC: ASM Press; 1999:297-305.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptiblity testing. 7th edition. Approved standards. NCCLS document M2-A7. Wayne, Pa: National Committee for Clinical Laboratory Standards; 2000.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th edition. Approved standards. NCCLS document M7-A4. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1999.
13. Chuang YC, Liu JW, Ko WC, Lin KY, Wu JJ, Huang KY. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother. 1997;41: 2214-7.
14. Chuang YC, Ko WC, Wang ST, Liu JW, Kuo CF, Wu JJ, et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother. 1998;42:1319-22.
15. White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother. 1996;40:1914-8.
16. Moody JA, Gerding DN, Peterson LR. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods. Am J Med. 1987;82:44-54.
17. Norden CW, Wentzel H, Keleti E. Comparison of techniques for measurement of in vitro antibiotic synergism. J Infect Dis. 1979;140:629-33.
18. 14C-labeled streptomycin by enterococci. J Clin Invest. 1971:50:2580-4.
19. Eliopoulos GM, Farber BF, Murray BE, Wennersten C, Moellering RC Jr. Ribosomal resistance in clinical enterococcal to streptomycin isolates. Antimicrob Agents Chemother. 1984; 25:398-9.
20. Leclercq R, Dutka-Malen S, Brisson-Noël A, Molinas C, Derlot E, Arthur M, et al. Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis. 1992;15:495-510.
21. Murray BE. The life and times of Enterococcus. Clin Microbiol Rev. 1990;3:46-65.
22. Moellering RC Jr. Enterococcus species, Streptococcus bovis and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone; 2000:2147-56.
23. Huang HC, Wang HR, Hsieh LM. Antiproliferative effect of baicalein, a flavonoid from a Chinese herb, on vascular smooth muscle cell. Eur J Pharmacol. 1994;251:91-3.